Skip to main content

Table 2 Hearing recovery according to pure-tone audiometry

From: Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial

    

Averaged hearing level (dB)

Hearing improvement

Patient

Age

Gender

Days from onset

Before registration

12 weeks

24 weeks

12 weeks

24 weeks

1

54

M

19

88

77

75

SR

SR

2

36

F

31

62

55

60

NR

NR

3

46

M

21

107

81

86

SR

SR

4

29

F

24

107

95

95

SR

SR

5

38

M

19

65

64

62

NR

NR

6

72

M

29

98

97

97

NR

NR

7

49

M

17

111

105

105

NR

NR

8

49

F

26

47

42

42

NR

NR

9

55

M

21

104

78

75

SR

SR

10

55

F

29

52

57

57

NR

NR

11

60

F

27

37

33

32

NR

NR

12

35

F

21

76

68

66

NR

SR

13

59

M

23

90

79

78

SR

SR

14

58

M

32

60

81

77

NR

NR

15

60

F

26

63

40

39

SR

SR

16

36

M

19

56

51

46

NR

SR

17

33

F

18

88

88

87

NR

NR

18

61

F

25

92

72

74

SR

SR

19

42

F

15

111

89

92

SR

SR

20

23

F

18

79

22

18

MR

MR

21

45

F

26

95

82

77

SR

SR

22

45

M

28

87

84

85

NR

NR

23

60

F

23

108

84

86

SR

SR

24

26

M

20

109

92

86

SR

SR

25

55

M

21

37

34

35

NR

NR

  1. Average hearing level was the mean hearing level according to pure-tone audiometry at the five frequencies tested (0.25, 0.5, 1.0, 2.0 and 4.0 kHz). Hearing improvement was determined by the criteria shown in Table 1.
  2. MR = marked recovery; NR = no recovery; SR = slight recovery.
Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us